Category: Cellcept

  • Voclosporin (Lupkynis) for Lupus Nephritis

    Date:  August 23, 2021 Issue #:  1631 Summary:  Voclosporin (Lupkynis – Aurinia), an oral calcineurin inhibitor, has been approved by the FDA for use in combination with the antimetabolite immunosuppressant mycophenolate mofetil (Cellcept, and generics) and a corticosteroid for treatment of adults with active lupus nephritis. It is the first calcineurin inhibitor to be approved […]